Biblio

Export 181 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is X  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
J. C. Morris, Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A., “APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.”, Ann Neurol, vol. 67, no. 1, pp. 122-31, 2010.
D. Hu, Chen, M., Li, X., Daley, S., Morin, P., Han, Y., Hemberg, M., Weiner, H. L., and Xia, W., “ApoE ε4-dependent Alteration of CXCR3  CD127 CD4 T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251320123, 2025.
J. Yang, Zhang, R., Shi, C., Mao, C., Yang, Z., Suo, Z., Torp, R., and Xu, Y., “AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 157-169, 2017.
P. Ding, Gorenflo, M. P., Zhu, X., and Xu, R., “Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 92, no. 3, pp. 989-1000, 2023.
J. L. Del-Aguila, Fernández, M. Victoria, Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., Chasse, R., Harari, O., Goate, A., Xiong, C., Morris, J. C., and Cruchaga, C., “Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline.”, J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.
X. - X. Liu, Wu, P. - F., Liu, Y. - Z., Jiang, Y. - L., Wan, M. - D., Xiao, X. - W., Yang, Q. - J., Jiao, B., Liao, X. - X., Wang, J. - L., Liu, S. - H., Zhang, X., and Shen, L., “Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Population.”, J Alzheimers Dis, vol. 85, no. 2, pp. 829-836, 2022.
M. P. Gorenflo, Davis, P. B., Kendall, E. K., Olaker, V. R., Kaelber, D. C., and Xu, R., “Association of Aspirin Use with Reduced Risk of Developing Alzheimer's Disease in Elderly Ischemic Stroke Patients: A Retrospective Cohort Study.”, J Alzheimers Dis, vol. 91, no. 2, pp. 697-704, 2022.
L. M. Wright, Stein, T. D., Jun, G., Chung, J., McConnell, K., Fiorello, M., Siegel, N., Ness, S., Xia, W., Turner, K. L., and Subramanian, M. L., “Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1429-1438, 2019.
L. Wang, Davis, P. B., Volkow, N. D., Berger, N. A., Kaelber, D. C., and Xu, R., “Association of COVID-19 with New-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 2, pp. 411-414, 2022.
C. - H. Liu, Le Bu, X. -, Wang, J., Zhang, T., Xiang, Y., Shen, L. - L., Wang, Q. - H., Deng, B., Wang, X., Zhu, C., Yao, X. - Q., Zhang, M., Zhou, H. - D., and Wang, Y. - J., “The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1081-8, 2016.
L. Xie, Shinohara, R. T., Ittyerah, R., Kuijf, H. J., Pluta, J. B., Blom, K., Kooistra, M., Reijmer, Y. D., Koek, H. L., Zwanenburg, J. J. M., Wang, H., Luijten, P. R., Geerlings, M. I., Das, S. R., Biessels, G. Jan, Wolk, D. A., Yushkevich, P. A., and Wisse, L. E. M., “Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?”, J Alzheimers Dis, vol. 63, no. 1, pp. 217-225, 2018.
B
E. Schwertner, Pereira, J. B., Xu, H., Secnik, J., Winblad, B., Eriksdotter, M., Nägga, K., and Religa, D., “Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1307-1318, 2022.
S. Wang, He, B., Hang, W., Wu, N. H., Xia, L., Wang, X., Zhang, Q., Zhou, X., Feng, Z., Chen, Q., and Chen, J., “Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1385-1400, 2018.
A. Russu, Samtani, M. N., Xu, S., Adedokun, O. J., Lu, M., Ito, K., Corrigan, B., Raje, S., Liu, E., H Brashear, R., Styren, S., and Hu, C., “Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.”, J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
K. Ndukwe, Serrano, P. A., Rockwell, P., Xie, L., and Figueiredo-Pereira, M. E., “Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model.”, J Alzheimers Dis, p. 13872877251314777, 2025.
H. Li, Luo, X. - B., Xu, Y., and Hou, X. - Y., “A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.”, J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
C
F. P. M. Oliveira, Moreira, A. Paula, de Mendonça, A., Verdelho, A., Xavier, C., Barroca, D., Rio, J., Cardoso, E., Cruz, Â., Abrunhosa, A., and Castelo-Branco, M., “Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?”, J Alzheimers Dis, vol. 65, no. 1, pp. 89-97, 2018.
S. J. Fan, Xian, X. H., Li, L., Yao, X. G., Hu, Y. Y., Zhang, M., and Li, W. B., “Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1731-1743, 2018.
S. Chu, Xu, F., Su, Y., Chen, H., and Cheng, X., “Cerebral Amyloid Angiopathy (CAA)-Related Inflammation: Comparison of Inflammatory CAA and Amyloid-β-Related Angiitis.”, J Alzheimers Dis, vol. 51, no. 2, pp. 525-32, 2016.
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H., “Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
D. Li, Xie, Q., Xie, J., Ni, M., Wang, J., Gao, Y., Wang, Y., and Tang, Q., “Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
D. Li, Xie, Q., Xie, J., Ni, M., Wang, J., Gao, Y., Wang, Y., and Tang, Q., “Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
G. Silva Leandro, Evangelista, A. Feijó, Lobo, R. Rebouças, Xavier, D. Jordão, Moriguti, J. César, and Sakamoto-Hojo, E. Tiemi, “Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1483-1495, 2018.
Q. - Q. Xu, Shan, C. - S., Wang, Y., Shi, Y. - H., Zhang, Q. - H., and Zheng, G. - Q., “Chinese Herbal Medicine for Vascular Dementia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials.”, J Alzheimers Dis, vol. 62, no. 1, pp. 429-456, 2018.
J. Sun, Cai, R., Huang, R., Wang, P., Tian, S., Sun, H., Xia, W., and Wang, S., “Cholesteryl Ester Transfer Protein Intimately Involved in Dyslipidemia-Related Susceptibility to Cognitive Deficits in Type 2 Diabetic Patients.”, J Alzheimers Dis, vol. 54, no. 1, pp. 175-84, 2016.

Pages